These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5598022)

  • 21. The role of the neuraminidase of the infecting virus in the production of noninfectious (von Magnus) influenza virus.
    Meier-Ewert H; Dimmock NJ
    Virology; 1970 Nov; 42(3):794-8. PubMed ID: 5529982
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiviral effect of 1-aminoadamantane derivatives in vitro.
    Váczi L; Hankovszky H; Hideg K; Hadházy G
    Acta Microbiol Acad Sci Hung; 1973; 20(3):241-7. PubMed ID: 4361336
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of antineuraminidase serum on Sendai virus reproduction].
    Azadova NB; Kupradze SA; Zhdanov VM
    Vopr Virusol; 1971; 16(6):665-70. PubMed ID: 4334837
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).
    Palese P; Schulman JL; Bodo G; Meindl P
    Virology; 1974 Jun; 59(2):490-8. PubMed ID: 4364826
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral growth inhibition by a biguanidine derivative in tissue culture.
    Gergely L; Váczi L; Hadházy G; Tóth FD
    Acta Microbiol Acad Sci Hung; 1970; 17(1):29-33. PubMed ID: 5469521
    [No Abstract]   [Full Text] [Related]  

  • 26. Early events in arenavirus replication are sensitive to lysosomotropic compounds.
    Glushakova SE; Lukashevich IS
    Arch Virol; 1989; 104(1-2):157-61. PubMed ID: 2923547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection and in vitro properties of inhibitor-nonsensitive influenza A(H3N2) strains.
    Lecomte J; Boudreault A; Pavilanis V
    Can J Microbiol; 1974 Apr; 20(4):491-8. PubMed ID: 4857251
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic interaction between two influenza A-WS virus mutants. I. Characterization of the mutants.
    Tucková E; Vonka V; Stárek M
    Acta Virol; 1971 Sep; 15(5):337-44. PubMed ID: 4399131
    [No Abstract]   [Full Text] [Related]  

  • 29. Antivirus action of acrolein, glutaraldehyde and oxidized spermine.
    Bachrach U; Don S; Wiener H
    J Gen Virol; 1971 Dec; 13(3):415-22. PubMed ID: 4946219
    [No Abstract]   [Full Text] [Related]  

  • 30. [The behavior of genetically purified influenza A2 strains in cell cultures].
    Gerth HJ
    Zentralbl Bakteriol Orig; 1970; 215(1):26-37. PubMed ID: 4992213
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiviral activity of cyclooctylamine hydrochloride in cell culture and mouse systems.
    Flagg WB; Stanfield FJ; Haff RF; Stewart RC; Stedman RJ; Gold J; Ferlauto RJ
    Antimicrob Agents Chemother (Bethesda); 1968; 8():194-200. PubMed ID: 5753824
    [No Abstract]   [Full Text] [Related]  

  • 32. Actinomycin D and influenza virus multiplication in the chick embryo fibroblast.
    Gregoriades A
    Virology; 1970 Dec; 42(4):905-16. PubMed ID: 5530797
    [No Abstract]   [Full Text] [Related]  

  • 33. Susceptibility of picodnaviruses H1, RV and X14 to guanidine and to 2-(alphahydroxybenzyl)-benzimidazole. (Brief report).
    Cocuzza G
    Arch Gesamte Virusforsch; 1969; 26(3):301-4. PubMed ID: 5795749
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of actinomycin D on the synthesis of influenza virus-specific RNA.
    Sugiura A; Ueda M; Enomoto C
    Arch Gesamte Virusforsch; 1969; 26(1):105-17. PubMed ID: 4890919
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiviral activity of amantadine: a review of laboratory and clinical data.
    Oxford JS; Galbraith A
    Pharmacol Ther; 1980; 11(1):181-262. PubMed ID: 6159656
    [No Abstract]   [Full Text] [Related]  

  • 36. [New strategy for targeting influenza virus replication].
    Dias A; Bouvier D; Cusack S; Ruigrok RW; Crépin T
    Med Sci (Paris); 2009 Apr; 25(4):352-4. PubMed ID: 19409186
    [No Abstract]   [Full Text] [Related]  

  • 37. The mode of action of an antiviral substance from Penicillium cyaneo-fulvum.
    David-West TS; Cooke PM; Stevenson JW
    Can J Microbiol; 1968 Mar; 14(3):197-204. PubMed ID: 5690325
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatty radical-modified antisense oligodeoxynucleotides as effective inhibitors of influenza virus reproduction.
    Vinogradov SV; Pheoktistov VS; Kabanov AV
    Nucleic Acids Symp Ser; 1991; (24):281. PubMed ID: 1841339
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitivity of influenza A2 virus to the non-specific alpha-inhibitor of Francis (the thermoresistance of the sialidase of several variants of influenza A2 virus)].
    Fridman EA; Vishnevskiĭ VG; Sinitskiĭ AA
    Vopr Virusol; 1969; 14(6):691-5. PubMed ID: 5369469
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids).
    Serkedjieva J; Manolova N; Bankova V
    J Nat Prod; 1992 Mar; 55(3):294-302. PubMed ID: 1593279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.